Tickets now on sale for 2023 Manufacturing Chemist Live

Published: 1-Feb-2023
Manufacturing Ingredients Packaging Sustainability Regulatory Drug Delivery Research & Development

Super early bird tickets are now on sale for the annual conference due to take place in Birmingham on 24 – 25 May 2023

Get your discounted ticket today!

Attended by over 350 representatives from companies such as GSK, AstraZeneca, Pfizer and many more, the two-day co-located event with Cleanroom Technology Conference, is the place to be for pharmaceutical professionals, as well as using cleanrooms to showcase, network and do business.

Super early bird tickets are now on sale and offer more than 35% discount on full price conference tickets

Cutting-edge content

The pharmaceutical manufacturing world is in a state of flux. Mega-trends such as automation, digitalisation, modularisation and serialisation are affecting the way companies work and the quality standards they have to meet. But how do they stay current? Are they Pharma 4.0 compatible? Is their plant ready for inspection? Is their facility future-proof and fit for purpose?

The venue

Based at the National Conference Centre in Birmingham, it's at the hub of the country’s motorway system and rail network, with Birmingham International railway station just five-minutes taxi ride away.

For more information, visit the website here or contact Amandine Mareschi on amandine@hpcimedia.com.

  • Companies:
  • GlaxoSmithKline
  • Pfizer
  • AstraZeneca
See more

You may also like

Regulatory

Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi

Read more
The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector format

Trending Articles

  1. Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future To safeguard drug efficacy, maintain strict quality standards and ensure patient safety, pharmaceutical packaging is subject to a wide range of regulations around the world, reports Kun Shing Chan, Director of QA at Tjoapack
  2. IMA Life and RheaVita team up to commercialise continuous biopharmaceutical freeze-drying tech The companies will work in tandem to develop and commercialise its continuous freeze-drying technology, allowing the rapid production of complex biopharmaceuticals
  3. Transmission Raman Spectroscopy - access the webinar series today Offering significant advantages for bulk, quantitative and non-destructive analysis, Transmission Raman Spectroscopy is a preferred choice for applications where surface analysis is insufficient or prone to errors. Speakers from Agilent, Novartis Pharma, AstraZeneca, Bristol-Myers Squibb and AbbVie go deeper in this FREE webinar series
  4. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Regulatory

Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi

The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector format
Manufacturing

AstraZeneca invests $3.5bn into its US pharmaceutical research and manufacturing capabilities

The company will expand its biologics manufacturing, as well as its speciality manufacturing and cell therapy production capacity, while also extending its pharmaceutical research and development capabilities through this investment
Drug Delivery

AstraZeneca and Amgen's Tezspire meets primary endpoints in Phase III trial

The Phase III WAYPOINT trial demonstrated Tezspire's ability to reduce nasal polyps and congestion compared to placebo when administered subcutaneously
Ingredients

Therapeutic: brensocatib for bronchiectasis

The chronic lung disease bronchiectasis is a serious condition in which the bronchi become permanently dilated because of a cycle of infection, inflammation and damage to the lung tissue
Manufacturing

GSK bolsters its US drug manufacturing capabilities with $800m investment

The expansion will double the size and capacity of its Marietta site, supporting the manufacture of sterile liquid vaccines and production for clinical trials
Regulatory

AstraZeneca's Wainzua recommended for EU approval to treat amyloidosis

The neuropathy drug was developed in tandem with Ionis, and has been shown to reduce neuropathy and increase quality of life in the Phase III NEURO-TTransform trial
Regulatory

Pfizer's haemophilia A/B therapeutic Hympavzi gains FDA approval

The pharma giant's once-weekly injectable can be administered subcutaneously and is able to significantly reduce annualised bleeding
Subscribe now